Related Experiment Video
Updated: Jun 7, 2026

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice
Published on: January 7, 2019
MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease
Geert R Van Pottelberge1, Pieter Mestdagh, Ken R Bracke
1Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
Rationale:
Chronic obstructive pulmonary disease (COPD) is characterized by progressive inflammation in the airways and lungs combined with disturbed homeostatic functions of pulmonary cells. MicroRNAs (miRNAs) have the ability to regulate these processes by interfering with gene transcription and translation.
Objectives:
We aimed to identify miRNA expression in induced sputum and examined whether the expression of miRNAs differed between patients with COPD and subjects without airflow limitation.
Methods:
Expression of 627 miRNAs was evaluated in induced sputum supernatant of 32 subjects by stem-loop reverse transcription-quantitative polymerase chain reaction. Differentially expressed miRNAs were validated in an independent replication cohort of 41 subjects. Enrichment of miRNA target genes was identified by in silico analysis. Protein expression of target genes was determined by ELISA.
Measurements And Main Results:
Thirty-four miRNAs were differentially expressed between never-smokers and current smokers without airflow limitation in the screening cohort. Eight miRNAs were expressed at a significantly lower level in current-smoking patients with COPD compared with never-smokers without airflow limitation. Reduced expression of let-7c and miR-125b in patients with COPD compared with healthy subjects was confirmed in the validation cohort. Target genes of let-7c were significantly enriched in the sputum of patients with severe COPD. The concentration of tumor necrosis factor receptor type II (TNFR-II, implicated in COPD pathogenesis and a predicted target gene of let-7c) was inversely correlated with the sputum levels of let-7c .
Conclusions:
let-7c is significantly reduced in the sputum of currently smoking patients with COPD and is associated with increased expression of TNFR-II.
Insights
MicroRNAs (miRNAs) like let-7c are reduced in chronic obstructive pulmonary disease (COPD) patients, correlating with increased TNFR-II. This finding offers insights into COPD pathogenesis and potential therapeutic targets.
Area of Science:
- Pulmonary Medicine
- Molecular Biology
- Genetics
Background:
- Chronic obstructive pulmonary disease (COPD) involves progressive airway inflammation and disrupted pulmonary cell homeostasis.
- MicroRNAs (miRNAs) are key regulators of gene expression, influencing cellular processes relevant to COPD.
Purpose of the Study:
- To identify specific miRNA expression profiles in induced sputum of COPD patients.
- To compare miRNA expression between COPD patients and individuals without airflow limitation.
Main Methods:
- Quantitative polymerase chain reaction (qPCR) was used to evaluate the expression of 627 miRNAs in sputum supernatant.
- Differential expression was validated in an independent cohort, followed by in silico target gene analysis and ELISA for protein validation.
Main Results:
- Thirty-four miRNAs showed differential expression between smokers and non-smokers without airflow limitation.
- Eight miRNAs, including let-7c and miR-125b, were significantly downregulated in COPD patients compared to healthy individuals.
- Reduced let-7c levels in severe COPD sputum correlated with increased tumor necrosis factor receptor type II (TNFR-II) protein.
Conclusions:
- let-7c is significantly decreased in the sputum of current smokers with COPD.
- The reduced let-7c expression is associated with elevated TNFR-II levels, suggesting a role in COPD pathogenesis.
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Microbiota of the Respiratory Tract
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease I: Introduction
MicroRNAs

